S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
GOOGL   1,484.17 (+0.13%)
AMZN   1,887.46 (-0.24%)
CGC   24.12 (-0.12%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
MU   59.17 (+0.34%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
ACB   2.04 (+1.49%)
F   9.16 (-0.54%)
NFLX   326.00 (-3.58%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
DIS   144.01 (+0.31%)
GILD   63.43 (+1.28%)
S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
GOOGL   1,484.17 (+0.13%)
AMZN   1,887.46 (-0.24%)
CGC   24.12 (-0.12%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
MU   59.17 (+0.34%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
ACB   2.04 (+1.49%)
F   9.16 (-0.54%)
NFLX   326.00 (-3.58%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
DIS   144.01 (+0.31%)
GILD   63.43 (+1.28%)
S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
GOOGL   1,484.17 (+0.13%)
AMZN   1,887.46 (-0.24%)
CGC   24.12 (-0.12%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
MU   59.17 (+0.34%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
ACB   2.04 (+1.49%)
F   9.16 (-0.54%)
NFLX   326.00 (-3.58%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
DIS   144.01 (+0.31%)
GILD   63.43 (+1.28%)
S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
GOOGL   1,484.17 (+0.13%)
AMZN   1,887.46 (-0.24%)
CGC   24.12 (-0.12%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
MU   59.17 (+0.34%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
ACB   2.04 (+1.49%)
F   9.16 (-0.54%)
NFLX   326.00 (-3.58%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
DIS   144.01 (+0.31%)
GILD   63.43 (+1.28%)
Log in
(Ad)
What if you could buy one tiny stock today for $10 - at the center of a growing tech industry - that experts believe will explode a massive 77,400%? Wall Street legend Paul Mampilly recently identified this as the stock of the century. Buying up a handful of shares of this small company now could change your life and even make you millions.

NASDAQ:SLGL - Sol Gel Technologies Stock Price, Forecast & News

$13.15
-0.26 (-1.94 %)
(As of 01/22/2020 04:00 PM ET)
Today's Range
$12.90
Now: $13.15
$13.75
50-Day Range
$8.36
MA: $11.82
$17.15
52-Week Range
$5.71
Now: $13.15
$21.00
Volume40,704 shs
Average Volume94,722 shs
Market Capitalization$248.84 million
P/E RatioN/A
Dividend YieldN/A
Beta1.19
Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include TWIN and SIRS-T, which has completed Phase II clinical trials for the treatment of acne vulgaris; and VERED that has completed Phase II clinical trials for the treatment of papulopustular rosacea. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SLGL
CUSIPN/A
Phone972-8931-3429

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$130,000.00
Book Value$3.38 per share

Profitability

Net Income$-32,200,000.00
Net Margins-223.99%

Miscellaneous

EmployeesN/A
Market Cap$248.84 million
Next Earnings Date3/19/2020 (Estimated)
OptionableNot Optionable

Receive SLGL News and Ratings via Email

Sign-up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

Investors looking for the best way to potentially double their money in 2020 -- regardless of whether the overall markets are up or down -- should look no further than these 3 unique stocks.

This Special Report reveals the names of these stocks and provides everything you need to invest right away.

Sol Gel Technologies (NASDAQ:SLGL) Frequently Asked Questions

What is Sol Gel Technologies' stock symbol?

Sol Gel Technologies trades on the NASDAQ under the ticker symbol "SLGL."

How were Sol Gel Technologies' earnings last quarter?

Sol Gel Technologies Ltd (NASDAQ:SLGL) posted its quarterly earnings results on Wednesday, November, 13th. The company reported ($0.37) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.25) by $0.12. The company earned $4.73 million during the quarter, compared to the consensus estimate of $6.56 million. Sol Gel Technologies had a negative net margin of 223.99% and a negative return on equity of 71.98%. View Sol Gel Technologies' Earnings History.

When is Sol Gel Technologies' next earnings date?

Sol Gel Technologies is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for Sol Gel Technologies.

What price target have analysts set for SLGL?

4 equities research analysts have issued 1-year price objectives for Sol Gel Technologies' shares. Their forecasts range from $23.00 to $33.00. On average, they anticipate Sol Gel Technologies' stock price to reach $26.50 in the next twelve months. This suggests a possible upside of 101.5% from the stock's current price. View Analyst Price Targets for Sol Gel Technologies.

What is the consensus analysts' recommendation for Sol Gel Technologies?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sol Gel Technologies in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sol Gel Technologies.

Has Sol Gel Technologies been receiving favorable news coverage?

Media coverage about SLGL stock has been trending somewhat positive on Wednesday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sol Gel Technologies earned a coverage optimism score of 1.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Sol Gel Technologies.

Are investors shorting Sol Gel Technologies?

Sol Gel Technologies saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 53,800 shares, an increase of 10.5% from the December 15th total of 48,700 shares. Based on an average trading volume of 80,700 shares, the short-interest ratio is presently 0.7 days. Approximately 1.4% of the shares of the company are sold short. View Sol Gel Technologies' Current Options Chain.

Who are some of Sol Gel Technologies' key competitors?

What other stocks do shareholders of Sol Gel Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sol Gel Technologies investors own include Amarin (AMRN), Iovance Biotherapeutics (IOVA), NVIDIA (NVDA), Applied Optoelectronics (AAOI), Adaptimmune Therapeutics (ADAP), Aqua Metals (AQMS), Arena Pharmaceuticals (ARNA), Inovio Pharmaceuticals (INO), Ligand Pharmaceuticals (LGND) and Mylan (MYL).

Who are Sol Gel Technologies' key executives?

Sol Gel Technologies' management team includes the folowing people:
  • Dr. Alon Seri-Levy, Co-Founder, CEO & Director (Age 58)
  • Mr. Gilad Mamlok, Chief Financial Officer (Age 51)
  • Mr. Itzik Yosef, VP of Operations (Age 43)
  • Dr. Ofer Toledano, VP of R&D (Age 54)
  • Dr. Ofra Levy-Hacham Ph.D., VP of Clinical & Regulatory Affairs (Age 53)

When did Sol Gel Technologies IPO?

(SLGL) raised $60 million in an IPO on Thursday, February 1st 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. ​Jefferies and BMO Capital Markets​ served as the underwriters for the IPO and JMP Securities and Raymond James​ were co-managers.

How do I buy shares of Sol Gel Technologies?

Shares of SLGL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Sol Gel Technologies' stock price today?

One share of SLGL stock can currently be purchased for approximately $13.15.

How big of a company is Sol Gel Technologies?

Sol Gel Technologies has a market capitalization of $248.84 million and generates $130,000.00 in revenue each year. The company earns $-32,200,000.00 in net income (profit) each year or ($1.80) on an earnings per share basis. View Additional Information About Sol Gel Technologies.

What is Sol Gel Technologies' official website?

The official website for Sol Gel Technologies is http://www.sol-gel.com/.

How can I contact Sol Gel Technologies?

Sol Gel Technologies' mailing address is 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA L3, 7403650. The company can be reached via phone at 972-8931-3429 or via email at [email protected]


MarketBeat Community Rating for Sol Gel Technologies (NASDAQ SLGL)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  111 (Vote Outperform)
Underperform Votes:  131 (Vote Underperform)
Total Votes:  242
MarketBeat's community ratings are surveys of what our community members think about Sol Gel Technologies and other stocks. Vote "Outperform" if you believe SLGL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLGL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel